Furthermore, they hypothesized that genetic risk factors for neurodegenerative disease at the MAPT site may play a role by altering mRNA splicing in different areas of the brain, rather than by the overall expression of the MAPT gene [28]. The gene discussed is MAPT; the disease is neurodegenerative disease.